Christina Rossi's most recent trade in Blueprint Medicines Corp was a trade of 1,172 Common Stock done at an average price of $128.3 . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 128.25 per share. | 03 Jul 2025 | 1,172 | 63,546 (0%) | 0% | 128.3 | 150,309 | Common Stock |
| Xilio Therapeutics Inc | Christina Rossi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 31,000 | 31,000 | - | - | Stock Option (right to buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 100.67 per share. | 19 May 2025 | 1,413 | 64,775 (0%) | 0% | 100.7 | 142,247 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 100.14 per share. | 19 May 2025 | 804 | 66,188 (0%) | 0% | 100.1 | 80,513 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 101.72 per share. | 19 May 2025 | 57 | 64,718 (0%) | 0% | 101.7 | 5,798 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 101.77 per share. | 05 May 2025 | 1,343 | 67,316 (0%) | 0% | 101.8 | 136,677 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 100.97 per share. | 05 May 2025 | 607 | 68,659 (0%) | 0% | 101.0 | 61,289 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 102.82 per share. | 05 May 2025 | 180 | 67,136 (0%) | 0% | 102.8 | 18,508 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 103.56 per share. | 05 May 2025 | 144 | 66,992 (0%) | 0% | 103.6 | 14,913 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 95.02 per share. | 24 Mar 2025 | 2,274 | 69,266 (0%) | 0% | 95.0 | 216,075 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 88.80 per share. | 05 Mar 2025 | 6,495 | 71,540 (0%) | 0% | 88.8 | 576,756 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 13,200 | 78,035 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 95.14 per share. | 20 Feb 2025 | 2,274 | 64,835 (0%) | 0% | 95.1 | 216,348 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 21 Jan 2025 | 816 | 68,038 (0%) | 0% | 110 | 89,760 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 110.78 per share. | 21 Jan 2025 | 808 | 67,230 (0%) | 0% | 110.8 | 89,510 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 108.99 per share. | 21 Jan 2025 | 529 | 68,854 (0%) | 0% | 109.0 | 57,656 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 111.81 per share. | 21 Jan 2025 | 121 | 67,109 (0%) | 0% | 111.8 | 13,529 | Common Stock |
| Blueprint Medicines Corp | Rossi Christina | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 95.88 per share. | 18 Dec 2024 | 2,166 | 69,491 (0%) | 0% | 95.9 | 207,676 | Common Stock |
| Blueprint Medicines Corp | Rossi Christina | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 96.50 per share. | 18 Dec 2024 | 108 | 69,383 (0%) | 0% | 96.5 | 10,422 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 95.10 per share. | 27 Nov 2024 | 2,274 | 71,657 (0%) | 0% | 95.1 | 216,257 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 9,625 | 73,931 (0%) | 0% | 0 | Common Stock | |
| Xilio Therapeutics Inc | Christina Rossi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 90.69 per share. | 07 Mar 2024 | 6,070 | 64,306 (0%) | 0% | 90.7 | 550,488 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 15,000 | 70,376 (0%) | 0% | 0 | Common Stock | |
| Xilio Therapeutics Inc | Christina Rossi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 45.72 per share. | 06 Mar 2023 | 2,960 | 55,475 (0%) | 0% | 45.7 | 135,331 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 44.28 per share. | 06 Mar 2023 | 99 | 55,376 (0%) | 0% | 44.3 | 4,384 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,000 | 58,435 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 45.24 per share. | 03 Nov 2022 | 533 | 43,435 (0%) | 0% | 45.2 | 24,113 | Common Stock |
| Xilio Therapeutics Inc | Christina Rossi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.28 per share. | 03 Mar 2022 | 1,197 | 45,526 (0%) | 0% | 60.3 | 72,155 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.19 per share. | 03 Mar 2022 | 1,047 | 44,479 (0%) | 0% | 56.2 | 58,831 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 15,000 | 46,723 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 86.61 per share. | 04 Mar 2021 | 1,272 | 31,723 (0%) | 0% | 86.6 | 110,168 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 89.10 per share. | 04 Mar 2021 | 87 | 32,995 (0%) | 0% | 89.1 | 7,752 | Common Stock |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 26,125 | 26,125 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 13,062 | 33,082 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Christina Rossi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 99.69 per share. | 03 Nov 2020 | 345 | 20,020 (0%) | 0% | 99.7 | 34,393 | Common Stock |